Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With a Malignant Glioma”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT02655601
What this trial is testing

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Who this might be right for
High Grade GliomaAstrocytoma, Grade IIIGlioblastoma
BioMimetix JV, LLC 177
Not applicableStudy completedNCT03471546
What this trial is testing

Early Palliative Care Intervention in Malignant Glioma

Who this might be right for
Malignant Glioma
Duke University 12
Testing effectiveness (Phase 2)Study completedNCT01977677
What this trial is testing

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Who this might be right for
Adult EpendymoblastomaAdult Giant Cell GlioblastomaAdult Glioblastoma+6 more
Lawrence Recht 30
Testing effectiveness (Phase 2)Study completedNCT00782756
What this trial is testing

Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Brain CancerMalignant Glioma
Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT00720564
What this trial is testing

Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00100802
What this trial is testing

Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Anaplastic AstrocytomaCentral Nervous System NeoplasmGlioblastoma+2 more
Children's Oncology Group 118
Very early researchStudy completedNCT01165632
What this trial is testing

Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+13 more
Mayo Clinic 24
Large-scale testing (Phase 3)Study completedNCT00017147
What this trial is testing

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
SWOG Cancer Research Network 183
Not applicableTemporarily pausedNCT05695976
What this trial is testing

GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM

Who this might be right for
GlioblastomaGlioma, Malignant
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT03746080
What this trial is testing

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcoma+2 more
Lawrence D Recht 21
Testing effectiveness (Phase 2)Ended earlyNCT00107471
What this trial is testing

Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain TumorsCentral Nervous System Tumors
Children's Oncology Group 7
Not applicableNot Yet RecruitingNCT07616726
What this trial is testing

Exploration and Characterization Ofintratumoral Electrophysiological Heterogeneity in Gliomas Using Magnetoencephalography

Who this might be right for
Patients Diagnosed With a Malignant Glioma
Hospices Civils de Lyon 60
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03581292
What this trial is testing

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Who this might be right for
Anaplastic AstrocytomaGlioblastomaMalignant Glioma
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT01220271
What this trial is testing

A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioma
Eli Lilly and Company 75
Testing effectiveness (Phase 2)Study completedNCT03463265
What this trial is testing

Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma

Who this might be right for
High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
Aadi Bioscience, Inc. 62
Early research (Phase 1)Study completedNCT06665724
What this trial is testing

Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Who this might be right for
Anaplastic Astrocytoma (AA)Anaplastic Oligodendroglioma (AO)Glioblastoma (GBM)
Universität Münster 16
Testing effectiveness (Phase 2)Study completedNCT00200161
What this trial is testing

Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma

Who this might be right for
GlioblastomaGliomas
Memorial Sloan Kettering Cancer Center 127
Testing effectiveness (Phase 2)UnknownNCT00313521
What this trial is testing

Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 30
Early research (Phase 1)Study completedNCT00357253
What this trial is testing

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 24
Next Page